Critical appraisal:Porceddu SV, Bressel M, Poulsen MG, Stoneley A, Veness MJ, Kenny LM, et al 2018 3
From Cancer Guidelines Wiki
Risk of bias assessment: Randomised Controlled Trial (Cochrane risk of bias tool)
Random sequence generation
Describe the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.

- Participants were randomly assigned in a ratio of 1:1 to RT or CRT. Stratified random assignment was used to balance the arms according to high-risk nodal disease and advanced primary/in-transit disease and institution.
In cases where participants had both risk categories, patients were stratified to the high-risk nodal group.
Allocation concealment
Describe the method used to conceal the allocation sequence in sufficient detail to determine whether intervention allocations could have been foreseen in advance of or during, enrolment.

- No response
Blinding
Describe all measures used, if any, to blind outcome assessors from knowledge of which intervention a participant received. Provide any information relating to whether the intended blinding was effective.

- No response
- Unclear
Incomplete outcome data
Describe the completeness of outcome data for each main outcome, including attrition and exlusions from the analysis. State whether attrition and exclusions were reported, the numbers in each intervention group (compared with total randomized participants), reasons for attrition/exclusions where reported, and any re-inclusions in analyses performed by the review authors.

- No response
Selective outcome reporting
State how the possibility of selective outcome reporting was examined by the review authors and what was found.

- No response
What was the risk of bias from selective outcome reporting? Assessments should be made for each main outcome (or class of outcomes).

- Low
Other sources of bias
Overall risk of bias
Unclear risk of bias | Additional comments: |
- Article
- Porceddu SV, Bressel M, Poulsen MG, Stoneley A, Veness MJ, Kenny LM, et al. Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial. J Clin Oncol 2018 May 1;36(13):1275-1283 Available from: http://www.ncbi.nlm.nih.gov/pubmed/29537906.
- Assigned to
- User:Albert.chetcuti
- Topic area
- Guidelines:Keratinocyte carcinoma
- Clinical question
- Form
- Form:Quality appraisal rct-cochrane
- Outcomes
- Locoregional control; Disease-specific survival; Overall survival
Section below only relevant for Cancer Council Project Officer